Overview

The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study

Status:
Recruiting
Trial end date:
2023-08-24
Target enrollment:
Participant gender:
Summary
To investigate the effectiveness of three (3) IV diuretic regimens to increase natriuresis in volume-overloaded HF patients, allowing for better decongestion and potentially resulting in improved clinical and biochemical parameters outcome.
Phase:
Phase 4
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Acetazolamide
Furosemide
Magnesium citrate
Metolazone